Board of Directors Samantha Lewis BA (Hons), CA Age 55 Independent Non-executive Director Director of CSL Limited since January 2024. Ms Lewis is an experienced non‑executive director serving on boards of ASX 100 companies since 2014. Ms Lewis is a chartered accountant with extensive experience in accounting, finance, auditing, risk management, corporate governance, capital markets and due diligence. Prior to becoming a Non‑executive Director, Ms Lewis spent 24 years with Deloitte, including 14 years as a Partner from 2000 until 2014. In that role, she acted as lead auditor of a number of major Australian listed entities and provided accounting and transactional advisory services including due diligence, IPOs and debt/equity raisings. Ms Lewis has significant experience working with companies in the manufacturing, retail and industrial sectors. She is currently a Non-executive Director at APA Group Limited and Australia Pacific Airports Corporation Limited. Other directorships and offices (current and recent): • Director of APA Group Limited (since October 2024); • Director of Australia Pacific Airports Corporation Limited (since October 2022); • Former Director of Nine Entertainment Co. Holdings Limited (from March 2017 to June 2025); • Former Director of Orora Limited (from March 2014 to April 2024); • Former Director of Aurizon Holdings Limited (from February 2015 to October 2023); and • Former Chair of APRA’s Audit and Risk Committee (from June 2016 to December 2022). Board Committee memberships: • Member Audit Risk Management Committee. Marie McDonald BSc (Hons), LLB (Hons) Age 69 Independent Non-executive Director Director of CSL Limited since August 2013. Ms McDonald has significant executive and non‑executive experience in a number of sectors including law, medical research, manufacturing and chemicals. Through these roles, Ms McDonald brings experience and insight on financial markets, risk and compliance and change management. Ms McDonald is a former lawyer with over 30 years’ experience in the legal sector. She was previously a Partner of Ashurst, specialising in mergers and acquisitions and corporate governance. She held the role of National Head of Mergers and Acquisitions and was Chair of the Corporations Committee of the Business Law Section of the Law Council of Australia and a member of the Australian Takeovers Panel for nine years. Other directorships and offices (current and recent): • Director of Telix Pharmaceuticals (since March 2025); • Member of the Law Committee of the AICD (since March 2023); • Director of Nufarm Limited (since March 2017); • Director of The Walter and Eliza Hall Institute of Medical Research (since October 2016); • Director of Nanosonics Limited (since October 2016); and • Former Member of Melbourne University Law School Foundation Board (from October 2021 to May 2025). Board Committee memberships: • Member of the Audit and Risk Management Committee; and • Member of the Human Resources and Remuneration Committee. Elaine Sorg BS Pharm Age 58 Independent Non-executive Director Director of CSL Limited since September 2024. Ms Sorg has more than 35 years’ experience as a senior executive with leading pharmaceutical companies including AbbVie and Eli Lilly. Prior to her retirement in 2023, Ms Sorg was Senior Vice President for AbbVie and President of AbbVie’s US commercial operations, the company’s largest commercial business. She was a key leader in bringing a number of groundbreaking medicines to patients across Immunology, Oncology, Neuroscience and Eye Care. Ms Sorg’s deep experience extends across biopharmaceutical industry and is recognised for her outstanding leadership and successfully building franchises and brands across therapeutic areas as well as segments. Ms Sorg holds a Bachelor of Science (Pharmacy) from Purdue University, as well as postgraduate certifications from the University of Chicago Booth School of Management and Harvard Business School. She is currently on the Dean’s Advisory Council at Purdue University School of Pharmacy and Pharmaceutical Science, and is a Senior Advisor at the Boston Consulting Group, where she advises global healthcare clients on business-critical strategies and decisions. Board Committee memberships: • Member of the Innovation and Development Committee. 44 Governance
RkJQdWJsaXNoZXIy MjE2NDg3